Important Disclosure Information. Read Before Proceeding.

Companies

Neuralink

Neuralink

San Francisco, CA

Founded 2016

Healthcare

Neuralink is a developer of brain-machine interfaces, building devices now that will help people with paralysis and inventing new technologies that will expand our abilities, our community, and our world.

neuralink.com|X (Twitter)|LinkedIn|Crunchbase

Last Round Valuation

$9.65B

Last Round Share Price

$ XX.XY

Total Funding

$1.29B

Last Round

Series E

Neuralink

$100.22

Fund Marks

1M

3M

YTD

1Y

2Y

MAX

Looking for Augment Collective?

Collective enables investments as low as $10k into private companies. We will prioritize those who have indicated interest on a first-come first-served basis.

Market

Viewing and creating orders is only available to accredited investors or verified shareholders. Log in to create an investment profile.

Funding Rounds

Nothing here

Information contained herein is based on estimates and is subject to update.

Mutual Funds

Ticker:All

Nothing here

Let us know if we are missing anything

News

Neuralink Reports 10,000 Registrations for Brain Trials thumbnail image

03/06/2026

Neuralink Reports 10,000 Registrations for Brain Trials

Neuralink's 10,000 trial registrations signal strong public interest and potential market validation, positioning the company favorably in the burgeoning neurotechnology sector, which could attract significant investment and accelerate its path to commercialization.

36 KrAOL.comMashable

Neuralink Launches Human Trials for Vision Restoration Device thumbnail image

01/29/2026

Neuralink Launches Human Trials for Vision Restoration Device

Neuralink's human trials for a vision restoration device could revolutionize the neurotechnology market, potentially attracting significant investment and partnerships, while positioning the company as a leader in addressing neurological disorders.

Aish.comEuronews.comSupercar Blondie

Neuralink Prepares for Mass Production After $650M Funding Round thumbnail image

01/28/2026

Neuralink Prepares for Mass Production After $650M Funding Round

Neuralink's $650M funding round positions it for mass production, potentially accelerating advancements in brain-computer interfaces and reshaping healthcare, while attracting further investment interest in neurotechnology's commercial viability.

3DVFBrinkwireMezhaBenzingaUniversity of Miami

Research

Neuralink One-Pager

Synchron One-Pager

Research reports obtained through third party are for informational purposes only.

Let us know if we are missing anything

FAQ

What is Augment?

Does Augment protect my privacy?

Who can use Augment?

Does my company allow sales of shares?

Are orders posted anonymously?

How do I know what price to buy or sell shares?

What size transactions does Augment support?

How can I get notified when there are new interested buyers of my shares?

Which companies are listed on Augment’s marketplace?

What is required to join Augment?

How do Augment fees work?

How do I know if an order is created by a broker or a direct buyer or user?

Is trading on Augment safe and legitimate?

What is the typical process of selling shares?

© Augment 2023 — All rights reserved. "Augment" refers to Augment Markets, Inc. and its affiliates. Augment Markets, Inc. is a technology company offering software and data services, in addition to financial products and services through its wholly-owned but separately managed subsidiary, Augment Capital, LLC.

Securities products are offered through Augment Capital, LLC, member FINRA/ SIPC. Any information relating to fully diluted shares outstanding or other company related financing or capitalization information are estimates only and should be independently verified by each user in connection with any investment decision. Company data and portfolio calculations are provided by Augment for educational and illustrative purposes only. None of the information displayed on or downloadable from augment.market (the "Website") represents a recommendation, offer, solicitation of an offer, advice, or recommendation to buy, sell, or hold any security. All investing involves risk, including the risk of losing the money you invest, and past performance does not guarantee future performance.

Using the website or the information, tools, features or functionality provided on the website and by Augment Capital, LLC constitutes acceptance of the Augment terms of use, privacy policy, and other important disclosures. Review our Form CRS here.